The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis

Alan Menter, Jennifer C. Cather, Diane Baker, Harold F. Farber, Mark Lebwohl, Mohamed Darif

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Abstract

Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval] vs placebo 2.30 [1.26-4.19]). Alefacept provided incremental efficacy over 5 successive 12-week treatment courses.

Original languageEnglish
Pages (from-to)61-63
Number of pages3
JournalJournal of the American Academy of Dermatology
Volume54
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Dive into the research topics of 'The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis'. Together they form a unique fingerprint.

Cite this